Gori M, Fappani C, Bianchi S, Tanzi E, Zuccotti G, Amendola A
J Prev Med Hyg. 2025; 65(4):E469-E472.
PMID: 40026430
PMC: 11870125.
DOI: 10.15167/2421-4248/jpmh2024.65.4.3190.
Gubbins S, Paudyal B, Dema B, Vats A, Ulaszewska M, Vatzia E
Front Immunol. 2025; 15:1506224.
PMID: 39749329
PMC: 11693722.
DOI: 10.3389/fimmu.2024.1506224.
Marron L, McKenna A, ODonnell J, Joyce M, Bennett C, Connell J
Influenza Other Respir Viruses. 2024; 18(12):e70023.
PMID: 39623514
PMC: 11611713.
DOI: 10.1111/irv.70023.
Zhao H, Zhou X, Fu K, Duan Y, Wen Q, Wang S
NPJ Vaccines. 2024; 9(1):51.
PMID: 38431710
PMC: 10908860.
DOI: 10.1038/s41541-024-00841-z.
Thwaites R, Uruchurtu A, Negri V, Cole M, Singh N, Poshai N
Nat Commun. 2023; 14(1):8053.
PMID: 38052824
PMC: 10697962.
DOI: 10.1038/s41467-023-43842-7.
Epidemiological Impact of the Pediatric Live Attenuated Influenza Vaccine (LAIV) Program on Group A (GAS) Infection in England.
Sinnathamby M, Warburton F, Guy R, Andrews N, Lamagni T, Watson C
Open Forum Infect Dis. 2023; 10(6):ofad270.
PMID: 37383247
PMC: 10296055.
DOI: 10.1093/ofid/ofad270.
An intercountry comparison of the impact of the paediatric live attenuated influenza vaccine (LAIV) programme across the UK and the Republic of Ireland (ROI), 2010 to 2017.
Sinnathamby M, Warburton F, Reynolds A, Cottrell S, ODoherty M, Domegan L
Influenza Other Respir Viruses. 2023; 17(2):e13099.
PMID: 36824392
PMC: 9942272.
DOI: 10.1111/irv.13099.
A New Grand Challenge in Rhinology: An Intranasal COVID Vaccine.
Scadding G
Front Allergy. 2022; 3:881118.
PMID: 35769553
PMC: 9234858.
DOI: 10.3389/falgy.2022.881118.
[Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra].
Boccalini S, Pariani E, Calabro G, de Waure C, Panatto D, Amicizia D
J Prev Med Hyg. 2021; 62(2 Suppl 1):E1-E118.
PMID: 34909481
PMC: 8639053.
DOI: 10.15167/2421-4248/jpmh2021.62.2s1.
Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.
Nguyen A, Arnold B, Kennedy C, Mishra K, Pokpongkiat N, Seth A
Vaccine. 2021; 40(2):266-274.
PMID: 34872797
PMC: 8881996.
DOI: 10.1016/j.vaccine.2021.11.073.
Nasal spray live attenuated influenza vaccine: the first experience in Italy in children and adolescents during the 2020-21 season.
Gasparini C, Acunzo M, Biuso A, Roncaglia S, Migliavacca F, Borriello C
Ital J Pediatr. 2021; 47(1):225.
PMID: 34774062
PMC: 8590342.
DOI: 10.1186/s13052-021-01172-8.
Influenza vaccine uptake among at-risk adults (aged 16-64 years) in the UK: a retrospective database analysis.
Oakley S, Bouchet J, Costello P, Parker J
BMC Public Health. 2021; 21(1):1734.
PMID: 34560879
PMC: 8460844.
DOI: 10.1186/s12889-021-11736-2.
City-wide school-located influenza vaccination: A retrospective cohort study.
Benjamin-Chung J, Arnold B, Mishra K, Kennedy C, Nguyen A, Pokpongkiat N
Vaccine. 2021; 39(42):6302-6307.
PMID: 34535312
PMC: 8881995.
DOI: 10.1016/j.vaccine.2021.08.099.
Uptake and impact of vaccinating primary school children against influenza: Experiences in the fourth season of the live attenuated influenza vaccination programme, England, 2016/2017.
Sinnathamby M, Warburton F, Andrews N, Boddington N, Zhao H, Ellis J
Influenza Other Respir Viruses. 2021; 16(1):113-124.
PMID: 34405555
PMC: 8692804.
DOI: 10.1111/irv.12898.
Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study.
Cohen C, Kleynhans J, Moyes J, McMorrow M, Treurnicht F, Hellferscee O
Lancet Glob Health. 2021; 9(6):e863-e874.
PMID: 34019838
PMC: 8262603.
DOI: 10.1016/S2214-109X(21)00141-8.
Influenza vaccination: protecting the most vulnerable.
Tanner A, Dorey R, Brendish N, Clark T
Eur Respir Rev. 2021; 30(159).
PMID: 33650528
PMC: 9488965.
DOI: 10.1183/16000617.0258-2020.
Spatial patterns of lower respiratory tract infections and their association with fine particulate matter.
Asri A, Pan W, Lee H, Su H, Wu C, Spengler J
Sci Rep. 2021; 11(1):4866.
PMID: 33649419
PMC: 7921673.
DOI: 10.1038/s41598-021-84435-y.
Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
Cole M, Kundu R, Abdulla A, Andrews N, Hoschler K, Southern J
Clin Exp Immunol. 2020; 204(1):125-133.
PMID: 33314126
PMC: 7944357.
DOI: 10.1111/cei.13564.
Risk factors associated with outbreaks of seasonal infectious disease in school settings, England, UK.
Donaldson A, Harris J, Vivancos R, OBrien S
Epidemiol Infect. 2020; 148:e287.
PMID: 33203492
PMC: 7770374.
DOI: 10.1017/S0950268820002824.
Using emergency department syndromic surveillance to investigate the impact of a national vaccination program: A retrospective observational study.
Hughes H, Elliot A, Hughes T, Hungerford D, Morbey R, Smith G
PLoS One. 2020; 15(10):e0240021.
PMID: 33031389
PMC: 7544051.
DOI: 10.1371/journal.pone.0240021.